D68.69 Billable / specific Other thrombophilia
ICD-10-CM D68.69 identifies “Other thrombophilia” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 3: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
Code-level instructions
Inclusion terms3
- COVID-19 associated hypercoagulability
- Hypercoagulable states NEC
- Secondary hypercoagulable state NOS
Code also1
, if applicable, associated condition
Inherited instructions
Chapters 3 · Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Excludes 29
- autoimmune disease (systemic) NOS (M35.9)
- certain conditions originating in the perinatal period (P00-P96)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- human immunodeficiency virus [HIV] disease (B20)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
D68 · Other coagulation defects
Excludes 11
abnormal coagulation profile NOS (R79.1)
D68.6 · Other thrombophilia
Inclusion terms1
Other hypercoagulable states
Official index references
Official index references (4)
Hypercoagulable(state) (2)
- Hypercoagulable(state) › secondaryDisease index
- Hypercoagulable(state) › specified NECDisease index
Thrombophilia (2)
- Thrombophilia › secondary NECDisease index
- Thrombophilia › specified NECDisease index
References from other codes (6)
Excludes 1 · secondary activated protein C resistance (D68.69)
Excludes 1 · secondary antiphospholipid antibody syndrome (D68.69)
Excludes 1 · secondary lupus anticoagulant with hypercoagulable state (D68.69)
Excludes 1 · secondary systemic lupus erythematosus [SLE] inhibitor with hypercoagulable state (D68.69)
Use additional code · hypercoagulable states (D68.69)
Use additional code · thrombophilia (D68.69)
History
Code history
Latest recorded change · FY2024
Effective from
- Code-level rules changed
Other thrombophilia
Billable diagnosis code
CDC/NCHS · FY2024All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | Inherited rules changed |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Code-level rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 289.82 · Approximate
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.